← Leaderboards
Richard A. Nash
Fred Hutchinson Cancer Research Center
$4,254,842
Attributed
$4,254,842
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $986.7K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$4,254,842 · 5
By mechanism
R01$3,440,250 · 2
R21$469,479 · 1
R34$330,211 · 1
RC1$14,902 · 1
Top collaborators
No co-investigators on record.
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- George Earl Georges$15,152,269
- Rainer F. Storb$23,835,935
- Lauri M. Burroughs$850,274
- Brenda Marie Sandmaier$22,185,663
- Robert Neil Eisenman$37,903,199
Others in their field
Top investigators on “Hematopoietic Stem Cells”
- Mary M Horowitz · Medical College Of Wisconsin$222,127,419
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$80,540,126
- David T Scadden · Massachusetts General Hospital$40,987,034
- David A Williams · Indiana Univ-Purdue Univ At Indianapolis$36,503,708
- Irving Lerner Weissman · Stanford University$36,281,548
- Bruce R. Blazar · University Of Minnesota$33,175,355
Research focus
Hematopoietic Stem CellsGanciclovirGraft Versus Host DiseaseHistocompatibilityDogsCytotoxic T LymphocyteMajor Histocompatibility ComplexCanis FamiliarisPre-ClinicalHistocompatibility TypingTransplantation ImmunologyTransplant RejectionHomologous TransplantationDrug Adverse EffectPolymerase Chain ReactionIn VivoHla AntigensBlood TransfusionClinical ResearchImmunosuppressiveHematopoieticCell TransplantationActive ImmunizationEnd Point
Grant awards (13)
Mitigation of Radiation-Induced Lung Injury in the Dog Model$14,902
RC1 · FY2010 · AI · contact PI
Protection from GVHD with Gene-Modified Donor T Cells$377,773
R01 · FY2008 · DK · contact PI
Protection from GVHD with Gene-Modified Donor T Cells$385,484
R01 · FY2007 · DK · contact PI
Lung Transplantation and Immune Tolerance in Young Recipients$209,979
R21 · FY2007 · AI · contact PI
Protection from GVHD with Gene-Modified Donor T Cells$396,997
R01 · FY2006 · DK · contact PI
Nonmyeloablative Hematopoietic Cell Transplantation for Severe Systemic Sclerosis$330,211
R34 · FY2006 · AI · contact PI
Lung Transplantation and Immune Tolerance in Young Recipients$259,500
R21 · FY2006 · AI · contact PI
Protection from GVHD with Gene-Modified Donor T Cells$406,550
R01 · FY2005 · DK
Protection from GVHD with Gene-Modified Donor T Cells$406,550
R01 · FY2004 · DK
HEMATOPOIETIC GROWTH FACTORS IN A CANINE STEM CELL MODEL$169,396
R01 · FY2003 · DK
ENGRAFTING SENSITIZED HOSTS WITH NONABLATIVE REGIMENS$432,500
R01 · FY2002 · HL
ENGRAFTING SENSITIZED HOSTS WITH NONABLATIVE REGIMENS$432,500
R01 · FY2001 · HL
ENGRAFTING SENSITIZED HOSTS WITH NONABLATIVE REGIMENS$432,500
R01 · FY2000 · HL